The pharma industry has been slower to adopt digital technologies than other less-regulated sectors. But many pharmaceutical companies making aggressive digital investments are beginning to see a payoff. Though comprehensive digital-based programs can cost roughly $50 million to $100 million annually for two to three years, according to McKinsey, they can lead to improved quality, increased…